
Hey iPad owners, this fun video shows how you can combine the "two greatest inventions of mankind" -- the iPad and Velcro -- to find unique and quirky uses for the device at home, on the road and in the office.

Hey iPad owners, this fun video shows how you can combine the "two greatest inventions of mankind" -- the iPad and Velcro -- to find unique and quirky uses for the device at home, on the road and in the office.

Shares of medical device makers fell after Moody's Investors Service warned the industry may face pricing pressure as more doctors leave private practice to form alliances with hospitals and other large healthcare systems.

It's been a rough ride for drug developers over the past week: Lawsuits, clinical-trial failures and warnings, and an investigation into possible insider trading hammered biotech stocks over the last week. We tally the damage.

Preferred stocks have been paying fat dividends over the last few years, as struggling companies offer higher yields to attract investors. A reader asks about pros and cons of investing in these stock/bond hybrids.

Senate lawmakers reached an agreement to delay the 21 percent reduction in Medicare claims reimbursements, on the day the cuts were scheduled to going into effect. The bill now moves on to the House for approval.

The nation's five largest health insurers processed 20% of claims incorrectly in 2009, a new study shows. The inaccuracies resulted in backlogs in processing, anger and confusion among patients, and wasted time and delayed payments for physicians.

Biotech stocks made up a big chunk at the annual "reconstituting" of the Russell 3000 Index. Each year around this time, the Russell 3000 is reconfigured and stocks are added to the widely held index. Here's a look at some up-and-coming biotechs about to join the widely held index.

Physician practices are consolidating at a record pace, driven by payments cuts embedded in the federal health reforms, a new survey finds. Small cardiology practices, which have seen the deepest cuts in Medicare payments, are among the most likely to be acquired by larger providers.

With oil spewing in the Gulf, and ash clouding the skies over Europe, travelers are understandably worried about natural events or disasters spoiling their summer vacations. One reader asks for help in choosing the right travel insurance policy.

In this rate environment, cash investors get short-changed. So what's a cash-flush investor to do? CDs are safe, sure, but returns are paltry. If you can stomach slightly more risk, consider these alternatives.

Biotech investors were on the lookout for this year's "sleeper hit" at the American Society of Clinical Oncology's annual cancer-drug conference. Here are 10 companies with share prices under $10 that generated significant buzz on Wall Street heading into the conference.

A reader says her mortgage broker is urging her to refinance her mortgage. She wants to know if it's a smart financial move for her, or if her broker is just looking for another commission.

Lawmakers infuriated doctors groups Friday after once again failing to act on the 21 percent Medicare pay cut for physicians, slated to take effect June 1. The Centers for Medicare and Medicaid Services notified physicians it will delay processing claims for two weeks.

The Gulf of Mexico undersea oil disaster has spawned a growing tide of investment scams from con artists who claim to be profiting from cleanup operations. Here's how to spot an oil-spill stock scam, and what to do if you suspect you're a victim.

A reader asks for help in finding a lawyer qualified to investigate an investment broker's suspected misuse of his account. There are several government Web sites and association directories that can help find an expert securities lawyer -- but investors need to act fast.